Workflow
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run?

A strong stock as of late has been Supernus Pharmaceuticals (SUPN) . Shares have been marching higher, with the stock up 6.1% over the past month. The stock hit a new 52-week high of $51.78 in the previous session. Supernus has gained 36.9% since the start of the year compared to the 1.6% gain for the Zacks Medical sector and the 2.2% return for the Zacks Medical - Generic Drugs industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed ...